PATENT CLAIM ANALYSIS

Application Number: 15946943
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "017200"]

Abstract:
Methods and compositions for modulating JNK activity and stimulating efferocytosis in a cell or patient are described. Therapeutic modified collagens comprising a plurality of proteins characterized by Table 1 for use as JNK modulators are also described.

Claim (Index 3):
The method of  claim 2 , wherein said collagen comprises an amount of each of Type I, Type II, and Type III collagen, wherein the amount of Type I collagen is greater than the amount of Type II or Type III collagen, and wherein the amount of Type III collagen is greater than the amount of Type II collagen.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.21875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15540661', '15880490', '15110108', '14775667', '13809876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7541553598367152
- 35 USC 102 Novelty (BERT): 0.5407613595325679
- Combined Prediction Score: 0.7328159598063005
- Mean Citation Score: 236.3933
- Max Citation Score: 383.2831
- Similarity Product: 247.1561836117268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test